South Texas Blood & Tissue Center News

The South Texas Blood & Tissue Center, a subsidiary of BioBridge Global, offers a variety of ways for you to stay connected with us. You can read our latest press releases or Annual Reports. Visit the Events Page to find out what’s coming up. You can watch a video clip from a newscast, view past events in the Photo Gallery or read industry news. For the social media enthusiast, the BioBridge family is known as “Connect for Life,” and can be found on FacebookTwitter, LinkedIn and YouTube. Also visit the our official blog here.

Media is welcome to contact the Corporate Communications Department for more information. We offer:

Interviews with experts in their respective medical fields
  • Interviews with Life Links - community members touched by the services of BioBridge Global and its subsidiaries.
  • Informative tours of the facility
Please contact:
Corporate Communications
Phone: (210) 731-5519
Mobile: (210) 296-9026


Recent News Articles

October 14, 2014

The ongoing Ebola outbreak in West Africa, which has now reached the United States and specifically Texas, has raised questions about the safety of blood donation and the blood supply. 

Dr. Rachel Beddard, BioBridge Global medical director, shares these important facts to keep in mind:

The South Texas Blood & Tissue Center, which is highly regulated by the Federal Drug Administration and other agencies, already safeguards our blood supply by requiring extra screening for potential donors who:

Present with any signs of illness. Symptoms include:

October 7, 2014

BioBridge Global and its subsidiaries - South Texas Blood & Tissue Center, QualTex Laboratories, GenCure and the Blood & Tissue Center Foundation - are featured in the September/October 2014 issue of San Antonio Woman magazine. A 16-page insert describes BioBridge Global’s history, subsidiaries and services. Click here to view the insert.

September 25, 2014

Dear Committed Lifesavers, 

We are calling on all blood donors with type A or O blood types to donate today! We are currently experiencing a high usage of these blood types due to the lifesaving treatment of area trauma and transplant patients. These are your donations hard at work, but more donors are still needed to replenish the community blood supply. This ensures hospitals have this resource when needed by other patients.

We encourage you to call us to set up your next appointment and/or check your donation eligibility. Please call 210-731-5590 or 800-292-5534 ext. 3500 or visit to schedule your appointment today!

August 29, 2014

The South Texas Blood & Tissue Center (STBTC) will be one of the first blood banks to use the VeinViewer® Flex, a product of Christie Medical, to help make blood donations more comfortable for young donors.

“With some donors, it’s difficult to find small veins for donation,” said Brian Clark, director of Donor Services at STBTC. “This technology we’ve invested in will help our phlebotomists find the right vein to help minimize discomfort during donation.”

The VeinViewer® Flex is a small instrument that projects near-infrared light that is absorbed by blood and reflected by surrounding tissue. The image is projected digitally in real time directly onto the surface of the skin. While the tool is not new technology and is currently utilized in hospital settings, it is new to the blood banking industry.

May 2, 2014

SAN ANTONIO, Texas, May 1, 2014 (GLOBE NEWSWIRE) -- Genetics Policy Institute (GPI) announced four prestigious "Organizing Partners" of the 10th annual World Stem Cell Summit. The 2014 Summit will be held December 3-5, 2014, at the San Antonio Marriott Rivercenter in San Antonio, Texas.

GPI, The University of Texas Health Science Center at San Antonio, Mayo Clinic, Kyoto University Institute for Integrated Cell-Material Sciences (iCeMS) and BioBridge Global will organize the 10th annual meeting of the global stem cell community, shaping the next year of progress in regenerative medicine. The annual event assembles the most prominent figures in the field to share research, build collaborations and find solutions to funding and commercialization challenges.